Clinical Trial Update: GLP-1 Mediating DPP-4 Inhibition in Type 2 Diabetes [Phase 4]

View source ↗

Summary

This update notes the completion of a Phase 4 trial examining GLP-1 mediated effects of DPP-4 inhibition in Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Diabeteszentrum Bad Lauterberg im Harz | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED